XML 17 R7.htm IDEA: XBRL DOCUMENT

Restructuring and Related Activities	6 Months Ended
Restructuring and Related Activities	Sep. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring and Impairment Costs Disclosure	RESTRUCTURING AND IMPAIRMENT COSTS Universal continually reviews its business for opportunities to realize efficiencies, reduce costs, and realign its operations in response to business changes. Restructuring and impairment costs are periodically incurred in connection with those activities. There were no restructuring and impairment costs incurred for the three and six months ended September 30, 2022. Tobacco Operations During the three months ended September 30, 2023, the Company began restructuring operations at our Global Labs Services ("GLS") facility in Wilson, NC. GLS provides testing for crop protection agents and tobacco constituents in seed, leaf, and finished products, including e-cigarette liquids and vapors, and has capabilities for testing non-tobacco products. As a result of the restructuring of the GLS operations, the Company incurred $1.8 million of restructuring and impairment costs for the three and six months ended September 30, 2023. During the three months ended September 30, 2023, the Company also incurred $0.8 million of termination costs in other areas of the Tobacco Operations segment.